USPTO 2015–2025 USPTO PatentsView Foreign Corporation

H. Lundbeck A/S

USPTO PatentsView assignee record - 258 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, H. ranks #1,603 of 49,997 tracked US assignees by granted-patent volume, with 258 patents across 16 technology areas.

#1,603
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.6/100)
16.4
avg claims per patent
+13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1603 · Foreign Corporation #1,603 · 258 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 258 grants
  • TOP-DECILE #1,603/49,997
  • PHOTO-FINISH Box
  • CPC-FOCUS A61P · 16 areas
  • INNOV-PAR 48.6/100
  • CLAIMS-RICH 16.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +13% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Box, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around H.

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows H.'s Innovation Score is 48.6/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where H.'s grants concentrate

H. Lundbeck A/S is a focused PatentsView assignee: 16 CPC subclasses with 88.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (35 grants) versus a trough of 17 in 2024. By volume, H. sits between Workday, Inc. and Flir Systems, Inc..

H.'s three-year grant acceleration

From 2019–2021 to 2022–2024, H. Lundbeck A/S moved from 80 to 66 grants (0.82x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,744. See the growth leaderboard.

Who files at H's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows H. holds 258 patents at rank #1,603, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near H

By rank, the assignees closest to #1,603 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in H's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for H, neither rank-band nor same-CPC leaders (those blocks stay above).

H.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

152025303540 20152016201720182019202020212022202320242025 22
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
H. Lundbeck A/S patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 26 10.1%
2016 18 7.0%
2017 25 9.7%
2018 21 8.1%
2019 21 8.1%
2020 24 9.3%
2021 35 13.6%
2022 28 10.9%
2023 21 8.1%
2024 17 6.6%
2025partial year 22 8.5%

Where it ranks

Overall rank by patents

#1,603

of 49,997 tracked assignees

Innovation Score

48.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

H. Lundbeck A/S's patent record in context - here's where to go next.

  • H. Lundbeck A/S's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 88.4% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #1,603 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare H. Lundbeck A/S against Workday, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.